SCHEMBL867969

SCHEMBL867969

CCN1CC(C)CC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16309343 0.83 CHRM2 (0.49)
SCHEMBL31443602 0.80
SCHEMBL10384952 0.80
SCHEMBL19905347 0.80
SCHEMBL19002725 0.79 L3MBTL1 (0.48)
SCHEMBL15228231 0.78 PER2 (0.44)
SCHEMBL15228275 0.78 CHRM2 (0.45)
SCHEMBL2560701 0.78 CHRM2 (0.49)
SCHEMBL3745079 0.78 CHRM2 (0.45)
SCHEMBL21389309 0.77 CHRM2 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102459383-B For the production of the solvent of polyurethane dispersions BASF SE (DE) 2015-08-26 CN claimed
US-20150024436-A1 SAMPLE PREPARATION, PROCESSING AND ANALYSIS SYSTEMS INTEGENX INC, (US) 2015-01-22 US claimed
US-8575244-B2 Solvents in the preparation of polyuretherane dispersions BASF SE (DE) 2013-11-05 US claimed
WO-2013130910-A1 SAMPLE PREPARATION, PROCESSING AND ANALYSIS SYSTEMS INTEGENX INC. (US) 2013-09-06 WO claimed
US-20120076932-A1 SOLVENTS IN THE PREPARATION OF POLYURETHERANE DISPERSIONS BASF SE (DE) 2012-03-29 US claimed
US-20250171841-A1 SAMPLE PREPARATION, PROCESSING AND ANALYSIS SYSTEMS INTEGENX INC. (US) 2025-05-29 US disclosed
US-12168798-B2 Sample preparation, processing and analysis systems INTEGENX. INC. (US) 2024-12-17 US disclosed
WO-2024044731-A1 DIAZEPINO-THIENO-QUINOXALINE COMPOUNDS AND THEIR USE IN THERAPY MATCHPOINT THERAPEUTICS INC. (US) 2024-02-29 WO disclosed
US-20230346951-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS YALE UNIVERSITY 2023-11-02 US disclosed
EP-4269388-A1 DIPYRROMETHENE-1-ONE COMPOUND AND PREPARATION METHOD THEREFOR Poseidon Pharmaceutical Co., Ltd. (CN) 2023-11-01 EP disclosed
EP-4269390-A1 BILIVERDIN COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Poseidon Pharmaceutical Co., Ltd. (CN) 2023-11-01 EP disclosed
US-20230339914-A1 INTERMEDIATE OF BILIVERDIN, AND PREPARATION METHOD AND USE THEREOF WUHAN JIANMIN DAPENG PHARMACEUTICAL CO., LTD. (CN) 2023-10-26 US disclosed
US-8575244-B2 Solvents in the preparation of polyuretherane dispersions BASF SE (DE) 2013-11-05 US disclosed
WO-2013130910-A1 SAMPLE PREPARATION, PROCESSING AND ANALYSIS SYSTEMS INTEGENX INC. (US) 2013-09-06 WO disclosed
EP-2440593-A1 NOVEL SOLVENTS FOR THE PRODUCTION OF POLYUTHERANE DISPERSIONS BASF SE (DE) 2012-04-18 EP disclosed
US-20120076932-A1 SOLVENTS IN THE PREPARATION OF POLYURETHERANE DISPERSIONS BASF SE (DE) 2012-03-29 US disclosed
WO-2010142617-A1 NOVEL SOLVENTS FOR THE PRODUCTION OF POLYUTHERANE DISPERSIONS BASF SE (DE) 2010-12-16 WO disclosed
EP-1423380-B1 PYRAZOLE-DERIVED KINASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2010-12-15 EP disclosed
US-7279476-B2 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-10-09 US disclosed
US-7279476-B2 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-10-09 US disclosed